Aanika Biosciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aanika Biosciences's estimated annual revenue is currently $2.6M per year.(i)
  • Aanika Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Aanika Biosciences has 17 Employees.(i)
  • Aanika Biosciences grew their employee count by -23% last year.

Aanika Biosciences's People

NameTitleEmail/Phone
1
CSO, Co-FounderReveal Email/Phone
2
Chief StaffReveal Email/Phone
3
CFO, Co-FounderReveal Email/Phone
4
SVP SalesReveal Email/Phone
5
Head Research and DevelopmentReveal Email/Phone
6
Scientist IIReveal Email/Phone
7
Scientist IReveal Email/Phone
8
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Aanika Biosciences?

Aanika Biosciences, Inc. provides food security services for large food and agricultural companies. We use synthetic biology to ensure the integrity of supply chains and reduce potential losses.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aanika Biosciences News

2022-04-13 - Berkeley Lights and Vestaron Announce Partnership to Develop Pesticidal Peptides Utilizing Proprietary High-Throughput, Functional Screening Service

... and enzyme engineering for pharmaceutical, life science, ... the recent Aanika Biosciences agreement and the Bayer Partnership in August...

2022-03-22 - Aanika Biosciences First Biotech Company to Receive ...

Aanika Biosciences was co-founded in 2018 by Vishaal Bhuyan after he personally experienced the consequences of ordering fresh, ethically...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M17-6%N/A
#2
$2.1M170%N/A
#3
$4.3M176%N/A
#4
$1.7M17-19%N/A
#5
$1.5M17N/AN/A